Price Transparency For MRIs Increased Use Of Less Costly Providers And Triggered Provider Competition
Price Transparency For MRIs Increased Use Of Less Costly Providers And Triggered Provider Competition
复制标题
DOI：
10.1377/hlthaff.2014.0168
复制
发表时间：
2014-08-01
期刊：
影响因子：
9.7
通讯作者：
DeVries, Andrea
中科院分区：
文献类型：
--
作者：
Wu, Sze-jung;Sylwestrzak, Gosia;DeVries, Andrea
为了鼓励患者选择高价值的供应商，保险公司发起的价格透明度计划，重点是选择先进的成像程序实施。根据参与该计划的商业健康计划（干预组）或不参与该计划的商业健康计划（参考组）的成员资格，将2010年或2012年至少接受过一次门诊磁共振成像（MRI）扫描的患者进行分组。在类似的美国地理区域。干预组的患者被告知现有MRI设备之间的价格差异，并可以选择不同的供应商。对于这些患者，该计划导致每次测试成本降低220美元（18.7%），医院设施的使用率从2010年的53%下降到2012年的45%。实施后，干预组的医院和非医院设施之间的价格差异减少了30%。居住在干预地区的非参与成员也看到价格下降，这表明供应商之间的价格竞争加剧。该计划大大降低了成像成本。这表明，患者在得知可用的替代品时会选择价格较低的设施。
To encourage patients to select high-value providers, an insurer-initiated price transparency program that focused on elective advanced imaging procedures was implemented. Patients having at least one outpatient magnetic resonance imaging (MRI) scan in 2010 or 2012 were divided according to their membership in commercial health plans participating in the program (the intervention group) or in nonparticipating commercial health plans (the reference group) in similar US geographic regions. Patients in the intervention group were informed of price differences among available MRI facilities and given the option of selecting different providers. For those patients, the program resulted in a $220 cost reduction (18.7 percent) per test and a decrease in use of hospital-based facilities from 53 percent in 2010 to 45 percent in 2012. Price variation between hospital and nonhospital facilities for the intervention group was reduced by 30 percent after implementation. Nonparticipating members residing in intervention areas also observed price reductions, which indicates increased price competition among providers. The program significantly reduced imaging costs. This suggests that patients select lower-price facilities when informed about available alternatives.